In vivo Piroxicam Metabolites: Possible Source for Synthesis of Central Nervous System (CNS) Acting Depressants

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 17, Iss. 3, 2017-10 ,pp. : 172-177

Bentham Science Publishers

Access to resources Recommend Favorite

Functional Chemical Groups that May Likely Become a Source for the Synthesis of Novel Central Nervous System (CNS) Acting Drugs

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 17, Iss. 3, 2017-10 ,pp. : 178-186

Bentham Science Publishers

Access to resources Recommend Favorite

Central Nervous System Acting Drugs in Treatment of Migraine Headache

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 12, Iss. 3, 2012-09 ,pp. : 158-172

Bentham Science Publishers

Access to resources Recommend Favorite

Computational Strategies to Predict Effect of P-Glycoprotein Transporter Efflux and Minimize its Impact on the Penetration of Drugs into the Central Nervous System (CNS)

By  

Current Computer - Aided Drug Design, Vol. 4, Iss. 1, 2008-03 ,pp. : 67-75

Bentham Science Publishers

Access to resources Recommend Favorite

Tuberculostatic Drugs Targeting Infections of the Central Nervous System

By Bartzatt Ronald  

Anti-Infective Agents, Vol. 10, Iss. 2, 2012-07 ,pp. : 87-94

Bentham Science Publishers

Access to resources Recommend Favorite